The disclosure provides bisindole suitable for inhibiting lipoxygenases or Aβ-formation, and treating associated diseases, such as Alzheimer's disease. The bisindoles are indolo[2,3-b]carbazole derivatives, and may be administered to a patient as part of a pharmaceutical formulation.
ANALOGS OF INDOLE-3-CARBINOL AND THEIR USE AS AGENTS AGAINST INFECTION
申请人:SRI International
公开号:EP2326327A2
公开(公告)日:2011-06-01
LIPOXYGENASE INHIBITORS
申请人:SRI International
公开号:EP2694057B1
公开(公告)日:2019-06-05
Lipoxygenase Inhibitors
申请人:SRI International, Inc.
公开号:US20130345214A1
公开(公告)日:2013-12-26
The disclosure provides bisindole suitable for inhibiting lipoxygenases or Aβ-formation, and treating associated diseases, such as Alzheimer's disease. The bisindoles are indolo[2,3-b]carbazole derivatives, and may be administered to a patient as part of a pharmaceutical formulation.